Science | Business International Editor David Matthews makes the case for IBBIS and details how IBBIS will work across sectors with researchers, funders, and industry stakeholders. In this January 2023 article featured on Science | Business’ website, Matthews writes, “A new global organisation is trying to prevent dramatic advances in bioscience from unleashing engineered pathogens from the lab, and wants research funders, scientists and journals to help.” IBBIS Executive Director Piers Millett, making the case for the need for IBBIS, adds: “This is going to be the century of biology…As we begin to be able to interfere with purpose in biological systems at whatever scale, the potential for something going wrong increases as well.” Read the article here.